Patten & Patten Inc Gilead Sciences, Inc. Transaction History

Patten & Patten Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $304,833 - $347,343	-5,381 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$62.1 - $78.08 $6,210 - $7,808	100 Added 1.89%	5,381 $340,000
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $72 - $84	1 Added 0.02%	5,281 $406,000
Q1 2020 Apr 16, 2020	BUY	$62.63 - $80.22 $330,686 - $423,561	5,280 New	5,280 $395,000
Q4 2017 Jan 22, 2018	SELL	$71.15 - $83.52 $184,278 - $216,316	-2,590 Closed	0 $0
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $186,764 - $221,367	2,590	2,590 $210,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

Stay updated on Patten & Patten Inc with notifications on news.